Through the use of histology guided mass spectrometry profiling and machine learning algorithms, we are able to evaluate the proteomic contents of targeted cells and develop a spectral fingerprint for disease diagnosis and treatment response. Our tests provide actionable intelligence, enabling physicians to develop personalized treatment plans and improve patient outcomes.
Our tests provide physicians with accurate and objective results that enable physicians to better develop treatment plans for patients. We provide physicians with an improved ability to more accurately diagnose a patient’s condition and predict whether a treatment or surgical procedure will be effective or necessary.
Our tests provide actionable intelligence, enabling physicians to develop personalized treatment plans and improve patient care. By targeting patient misdiagnosis, mistreatment, and overtreatment, we seek to help physicians improve patient outcomes and positively impact overall healthcare spending.